IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -50.0% | 78 | -15.2% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | 0.0% | 92 | -7.1% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | -33.3% | 99 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $3,000 | 0.0% | 99 | -8.3% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | -50.0% | 108 | -12.9% | 0.00% | -50.0% |
| Q4 2020 | $6,000 | +20.0% | 124 | -24.8% | 0.00% | +33.3% |
| Q3 2020 | $5,000 | +66.7% | 165 | +29.9% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | -40.0% | 127 | 0.0% | 0.00% | -40.0% |
| Q1 2020 | $5,000 | +150.0% | 127 | +69.3% | 0.01% | +150.0% |
| Q4 2019 | $2,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |